KPIs, or Key Performance Indicators, are essential metrics that provide a snapshot of a company's business performance over a specific period. These metrics are crucial for both the company and its investors. By looking at KPIs, companies can identify their strengths and address areas needing improvement, while investors can make more informed investment decisions.
Different KPIs reveal various aspects of a company's profitability, efficiency, liquidity, and operations. It’s important to understand that no single KPI can give a complete picture of a company's health. Analyzing multiple KPIs provides a more comprehensive understanding.
Let's dive into some common KPIs that companies use to assess their performance:
1. Understanding Revenue from Operations
Revenue from operations reflects the income a company earns from its main business activities. This includes the earnings from selling products or services but excludes income from other sources like investments or one-time gains. Often referred to as the "top line," this figure is crucial for gauging sales performance.
The primary focus is on the growth percentage of this revenue, as a growing turnover indicates a thriving company. For instance, Mukka Proteins Limited has shown significant revenue growth over the years:
Mukka Proteins Limited KPIs
| Mar-23 | Mar-22 | Mar-21 | Mar-20 | |
|---|---|---|---|---|
| Revenue from Operations (Rs. in crores) | 1177 | 770 | 604 | 549 |
| Growth in Revenue/Sales Growth (%) | 52.85% | 27.48% | 10.01% |
Points to Consider:
- An increasing growth percentage is a positive indicator.
- Consistent growth, while positive, might suggest limited sales expansion.
- A declining growth rate is a red flag.
2. Exploring Profit After Tax
Profit After Tax (PAT) is the net income left after all expenses and taxes have been paid. This figure is crucial for evaluating a company’s financial health, often referred to as the "bottom line." A higher PAT suggests efficient expense management and strong profitability.
PAT is derived by subtracting taxes and all other expenses from total income. A positive PAT indicates profitability, while a negative PAT denotes losses.
Mukka Proteins PAT
| Mar-23 | Mar-22 | Mar-21 | Mar-20 | |
|---|---|---|---|---|
| Profit After Tax | Rs 47.53 Cr | Rs 25.82 Cr | Rs 11.01 Cr | Rs 14.00 Cr |
Points to Consider:
- An increase in PAT is a strong positive sign.
- Consistent PAT is good, but should be monitored for potential growth.
- A decrease in PAT warrants caution.
- Sudden fluctuations might be one-time events; investigate the cause.
3. Delving into Profit After Tax Margin (PAT Margin)
The PAT Margin is expressed as a percentage of PAT against the company’s revenue from operations. This metric indicates how much of the company's sales translate into profit. A higher PAT Margin is a positive indicator of a company’s ability to manage costs and taxes effectively.
Mukka Proteins PAT Margin
| Mar-23 | Mar-22 | Mar-21 | Mar-20 | |
|---|---|---|---|---|
| PAT Margin | 4.04% | 3.35% | 1.82% | 2.55% |
Points to Consider:
- A higher PAT Margin is very favorable.
- A lower margin might still be acceptable but needs monitoring.
- Negative margins are concerning.
- Investigate significant changes for underlying causes.
4. Assessing Return on Capital Employed (RoCE)
Return on Capital Employed (RoCE) evaluates a company's profitability in relation to its total capital. It serves as a benchmark for investors to determine the efficiency of a company in generating profits from its capital.
RoCE is calculated by dividing operating profit by capital employed (total assets minus current liabilities). A higher RoCE is generally preferable, with 15-20% being considered good, though it varies by industry.
Mukka Proteins RoCE
| Mar-23 | Mar-22 | Mar-21 | |
|---|---|---|---|
| RoCE | 17.62% | 13.86% | 5.86% |
Points to Consider:
- An increasing RoCE is highly favorable.
- Consistent RoCE is positive but may lack growth.
- Decreasing RoCE is a warning sign.
- Analyze sudden changes for potential anomalies.
5. Examining Return on Equity (RoE)
Return on Equity (RoE) is another profitability metric that assesses a company's ability to generate profits from its equity. Unlike RoCE, RoE focuses solely on equity, excluding debt.
Calculated by dividing net profit by shareholder's equity, a higher RoE is generally better. However, industry norms should be considered, as RoE can vary significantly.
Mukka Proteins ROE
| Mar-23 | Mar-22 | Mar-21 | |
|---|---|---|---|
| RoE | 36.71% | 30.00% | 17.37% |
Points to Consider:
- An increasing RoE is a very positive sign.
- Consistent RoE is positive but may indicate limited growth.
- Decreasing RoE is a cautionary signal.
- Consider debt levels and other factors alongside RoE.
6. Analyzing Return on Net Worth (RONW%)
Return on Net Worth (RONW) measures a company’s profitability relative to its net assets, including equity and reserves. This ratio indicates how effectively a company utilizes its assets to generate profits.
RONW is calculated by dividing net income by shareholders' equity. A higher RONW is generally favorable.
Mukka Proteins RONW
| Mar-23 | Mar-22 | Mar-21 | |
|---|---|---|---|
| RONW | 34.19% | 27.75% | 13.91% |
Points to Consider:
- An increasing RONW is a strong positive sign.
- A consistent RONW is good but could imply a lack of growth.
- A decreasing RONW is a warning sign.
- Investigate sudden changes for underlying reasons.
7. Understanding Debt to Equity Ratio
The Debt to Equity Ratio provides insights into a company’s capital structure, indicating how much debt versus equity is used for financing. A high ratio suggests reliance on debt, which can be risky if the company struggles to meet its obligations.
An ideal debt-equity ratio varies by industry, typically between 1 and 1.5 to 2. Capital-intensive industries might have higher ratios.
Mukka Proteins Debt to Equity Ratio
| Mar-23 | Mar-22 | Mar-21 | |
|---|---|---|---|
| Debt Equity Ratio | 1.64 | 1.68 | 2.31 |
Points to Consider:
- A debt-equity ratio between 1-1.5 is generally good.
- Some industries naturally have higher ratios.
- A decreasing trend is favorable.
- An increasing trend is a cautionary sign.
8. Discovering Earnings per Share (EPS)
Earnings per Share (EPS) is a key profitability metric indicating how much profit is allocated to each share. This metric helps investors assess a company's performance.
EPS is derived by dividing net profit by the total number of outstanding shares. There are two types: basic EPS and diluted EPS. Diluted EPS accounts for convertible securities, while basic EPS does not.
Mukka Proteins Earnings Per Share
| Mar-23 | Mar-22 | Mar-21 | |
|---|---|---|---|
| EPS | 2 | 1.1 | 0.41 |
Points to Consider:
- An increasing EPS is a very positive sign.
- A consistent EPS is positive but may indicate limited growth.
- A decreasing EPS is a cautionary signal.
9. Evaluating Price to Earnings Ratio (PE Ratio)
The Price to Earnings Ratio (P/E) is crucial for assessing a company's stock valuation. It helps determine if a stock is undervalued or overvalued by comparing the current share price with EPS.
A P/E ratio is calculated by dividing the current share price by EPS. A lower P/E ratio is generally better, indicating a more reasonably priced stock. However, industry norms and future growth potential should be considered.
Mukka Proteins PE Ratio (Upper Price Band of Rs. 28)
| Mar-23 | Mar-22 | Mar-21 | |
|---|---|---|---|
| PE | 14 | 25.45 | 68.29 |
Points to Consider:
- A lower P/E ratio suggests a reasonably priced stock.
- A higher P/E ratio indicates an overpriced stock.
10. Exploring EBITDA Margin
The EBITDA Margin measures a company's operating profitability. EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. This margin provides insight into a company's operational efficiency.
To calculate the EBITDA margin, add finance costs, tax expense, and depreciation and amortization to PAT, then divide by revenue from operations. A margin of 10% or above is generally favorable.
Mukka Proteins EBITDA Margin
| Mar-23 | Mar-22 | Mar-21 | |
|---|---|---|---|
| EBITDA Margin | 8.01% | 7.04% | 5.27% |
Points to Consider:
- An increasing EBITDA margin is a positive sign.
- A decreasing trend warrants caution.
11. Understanding Price to Book Value
The Price to Book Value (P/B) ratio assesses whether a stock is undervalued or overvalued by comparing the market value of equity to its book value. A higher P/B ratio indicates overvaluation, while a lower ratio suggests undervaluation.
Calculated by dividing the market price per share by the net asset value per share, a P/B ratio of 1-3 is generally considered undervalued, although this varies by industry.
Mukka Proteins P/B Ratio
| Mar-23 | |
|---|---|
| P/BV | 4.78 |
Points to Consider:
- A P/B ratio of 1-3 indicates undervaluation.
- A P/B ratio of more than 15 suggests overvaluation.
- Compare P/B ratios with industry peers for a better understanding.
12. Grasping Market Capitalization
Market Capitalization, or Market Cap, represents the total market value of a company’s outstanding shares. It is a key metric for understanding the size and value of a company in the stock market.
Companies are categorized into large cap, mid cap, and small cap based on their market cap. Large cap companies (Rs 20,000 crore or more) are considered stable, while small cap companies (below Rs 5,000 crore) offer high growth potential but with higher risk.
How to Calculate Market Capitalization
Market Cap = Current Share Price × Total Number of Outstanding Shares
Example: Mukka Protein IPO
- Outstanding shares: 30,00,00,000 (Rs 30 crore)
- Price band: Rs 26-28
Market Cap (At upper price band) = 30 crore * 28/share = Rs 840 crore
Example: JSW Cement IPO
- Outstanding shares: 1,36,33,64,936
- Price band: Rs 139-147
Market Cap = 1363364936 * 147 = Rs 20,041.46 Crore
A higher market capitalization indicates a large cap company, often seen as more stable and attractive to investors.
13. KPI Analysis
To understand these metrics better, let's explore Mukka Protein's KPIs. Here's what the data reveals about the company:
Mukka Proteins KPI Analysis
| Mar 23 | Mar 22 | Mar 21 | KPI Analysis | |
|---|---|---|---|---|
| Revenue from Operations (Rs. in crore) | 1177 | 770 | 604 | Increasing revenue is a positive indicator. |
| Growth in Revenue/Sales Growth (%) | 52.85% | 27.48% | 10.01% | Rising sales growth is beneficial. |
| Profit After Tax (Rs. in crore) | 47.53 | 25.82 | 11.01 | Increasing PAT is favorable. |
| PAT Margin (%) | 4.04% | 3.35% | 1.82% | Growing PAT Margin is positive. |
| RoCE (%) | 17.62% | 13.86% | 5.86% | Rising RoCE is advantageous. |
| RoE (%) | 36.71% | 30.00% | 17.37% | Increasing RoE is beneficial. |
| RoNW (%) | 34.19% | 27.75% | 13.91% | Rising RoNW is favorable. |
| Debt/Equity Ratio | 1.64 | 1.68 | 2.31 | A decreasing ratio is advantageous. |
| P/E | 14 | 25.45 | 68.29 | Improving P/E is positive. |
| EPS | 2 | 1.1 | 0.41 | Rising EPS is favorable. |
| EBITDA Margin | 8.01% | 7.04% | 5.27% | Increasing margin is a good sign. |
| P/BV | 4.78 | Fairly priced. |
Therefore, based on the analysis of financial KPIs, applying for Mukka Proteins could be promising. However, it’s crucial to consider other factors like company reviews, sector growth, the object of the issue, and the management team before making an investment decision.
Key Takeaways
KPIs are instrumental in assessing a company's performance, determining its profitability and efficiency. They assist investors in deciding whether to invest in an IPO. It’s crucial to review all metrics, analyze trends, and compare them with industry peers for a well-rounded evaluation.